Back to article: Broad-spectrum antifungal activities and mechanism of drimane sesquiterpenoids

FIGURE 5: Yeast spot assay and molecular docking. (A) Validation of C. albicans Tn-insertion mutant screen data by yeast spot assay. A four-fold serially diluted yeast cultures of indicated C. albicans heterozygous mutants (GRACE) were spot tested on YPD agar containing 1 (30 μg/ml) or DMSO (− 1). Heterozygous mutants (RET2/-, Orf19.759/-, Orf19.1672/-, and Orf19.4382/-) directly or indirectly affected by 1 were hypersensitive and showed lack of growth. (B) Molecular docking of drimenol with the C. parvum Crk1 kinase. Molecular docking of 1 with C. parvum Crk1 crystal structure (2QKR-A) was performed using AutoDock Vina software.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.